SAN DIEGO — Erinn Maury knew Remicade wasn't the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte's swollen, painful ...

Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...

Credit: Celltrion. Yuflyma, a tumor necrosis factor blocker, was approved in May 2023 as a biosimilar to Humira. Similar PK, efficacy, safety, and immunogenicity data were observed between the ...

(Reuters) - Johnson & Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Inc's top-selling Humira in a large trial. By one measure, patients ...

Rheumatoid arthritis is a chronic autoimmune condition that affects the joints, causing inflammation, stiffness, and pain. Patients searching for popular rheumatoid arthritis prescriptions are often ...

Please provide your email address to receive an email when new articles are posted on . The risks for major adverse cardiac events and malignancy, excluding non-melanoma skin cancer, are similar ...

After they fail methotrexate, it's a TNF inhibitor, almost always Humira. And that's not OK." If there's a shred of hope in this story, it's that a blood test, PrismRA, may herald an era of improved ...

SAN DIEGO — Dr. Erinn Maury knew Remicade wasn't the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte's swollen, painful ...

After they fail methotrexate, it's a TNF inhibitor, almost always Humira. And that's not OK." If there's a shred of hope in this story, it's that a blood test, PrismRA, may herald an era of improved ...